| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/23/2014 | CN102058480B 一种口服泡腾片及其制备方法 An effervescent tablets and oral preparation |
| 07/23/2014 | CN101947194B 供凝胶分配器使用的方法和组合物 Methods and compositions for use in the gel dispenser |
| 07/23/2014 | CN101848735B 用于药物用途的neurturin缀合物 Neurturin conjugates for pharmaceutical use |
| 07/22/2014 | US8785569 Drug carrier with chelating complex micelles and the application thereof |
| 07/22/2014 | US8785426 Testosterone gel compositions and related methods |
| 07/22/2014 | US8785415 Oral formulations of cladribine |
| 07/22/2014 | US8785396 Method and composition for treating migraines |
| 07/22/2014 | US8785371 Drug delivery of temozolomide for systemic based treatment of cancer |
| 07/22/2014 | US8785212 Oligosaccharide modification and labeling of proteins |
| 07/22/2014 | US8785202 Colloidal metal compositions and methods |
| 07/22/2014 | US8785200 Transfection reagents |
| 07/22/2014 | US8784893 Polymer formulations for delivery of bioactive agents |
| 07/22/2014 | US8784892 Method and composition for burned skin |
| 07/22/2014 | US8784888 Controlled release and taste masking oral pharmaceutical composition |
| 07/22/2014 | US8784883 Capsule comprising low-substituted cellulose ether and method for preparing the same |
| 07/22/2014 | US8784880 Titratable dosage transdermal delivery system |
| 07/22/2014 | US8784872 Formulation for decreasing tobacco, alcohol, drug or food consumption |
| 07/22/2014 | US8784849 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 07/22/2014 | US8784848 Method for preparing a stable oil-in-water emulsion |
| 07/22/2014 | US8784843 Stabilizers for freeze-dried vaccines |
| 07/22/2014 | US8784825 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 07/22/2014 | US8784824 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 07/22/2014 | US8784792 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 07/22/2014 | US8784789 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 07/22/2014 | US8784786 Rheology modifier polymer |
| 07/22/2014 | CA2780137C Phototriggered nanoparticles for cell and tissue targeting |
| 07/22/2014 | CA2778826C Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 07/22/2014 | CA2656961C A topical anaesthetic composition |
| 07/22/2014 | CA2606510C Pharmaceutical preparation for oral administration comprising an imide compound |
| 07/22/2014 | CA2570324C Rage fusion proteins and methods of use |
| 07/22/2014 | CA2494756C Anti-tnf-alpha antibodies in solution and uses thereof |
| 07/22/2014 | CA2441809C Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses |
| 07/22/2014 | CA2405299C Method of treatment using ligand-immunogen conjugates |
| 07/17/2014 | WO2014110578A1 Releasable magnetic cell capture system |
| 07/17/2014 | WO2014110555A1 Compositions and methods for treating cancer |
| 07/17/2014 | WO2014110454A1 Stabilized compositions comprising hyaluronic acid |
| 07/17/2014 | WO2014110449A1 Stannous doped micro and nano particles for augmented radiofrequency ablation |
| 07/17/2014 | WO2014110389A1 Hybrid matrix |
| 07/17/2014 | WO2014108685A1 Pharmaceutical compositions |
| 07/17/2014 | WO2014108574A1 Solid solution compositions and use in severe pain |
| 07/17/2014 | WO2014108573A1 Solid solution compositions and use in chronic inflammation |
| 07/17/2014 | WO2014108572A1 Solid solution compositions and use in cardiovascular disease |
| 07/17/2014 | WO2014108547A1 A peptide conjugate suitable for use as an anti-cancer agent |
| 07/17/2014 | WO2014108474A1 Voriconazole inclusion complexes |
| 07/17/2014 | WO2014075203A8 Nanoparticles with biodegradable and biocompatible polymer plga, loaded with the drug for human use pentoxifylline |
| 07/17/2014 | WO2014053521A3 Nonlinear saccharide conjugates |
| 07/17/2014 | WO2013091001A9 A peptide-hydrogel composite |
| 07/17/2014 | WO2013086024A3 Dermal filler compositions |
| 07/17/2014 | US20140200654 Drug-delivery endovascular stent and method of forming the same |
| 07/17/2014 | US20140200531 Mixture for transdermal delivery of low and high molecular weight compounds |
| 07/17/2014 | US20140200516 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/17/2014 | US20140200278 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/17/2014 | US20140200257 Pegylated lipids and their use for drug delivery |
| 07/17/2014 | US20140200191 Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 07/17/2014 | US20140200182 Methods of administering bone morphogenetic protein compositions |
| 07/17/2014 | US20140199750 Monofunctional branched polyethylene glycol and modified bio-related substance thereof |
| 07/17/2014 | US20140199404 Method for treating cancer based on level of a nucleoside transporter |
| 07/17/2014 | US20140199403 Methods of treating pancreatic cancer |
| 07/17/2014 | US20140199401 Extended release pharmaceutical compositions of fesoterodine |
| 07/17/2014 | US20140199398 High capacity diektopiperazine microparticles and methods |
| 07/17/2014 | US20140199383 Abuse resistant opioid containing transdermal systems |
| 07/17/2014 | US20140199376 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 07/17/2014 | US20140199370 Cyclodextrin-based materials compositions and uses related thereto |
| 07/17/2014 | US20140199369 Pharmaceutical composition |
| 07/17/2014 | US20140199349 Ph-sensitive hyaluronic acid derivative and uses thereof |
| 07/17/2014 | US20140199331 Bio-orthogonal drug activation |
| 07/17/2014 | US20140199321 Stabilizing polypeptides which have been exposed to urea |
| 07/17/2014 | US20140199315 Sp35 Antibodies and Uses Thereof |
| 07/17/2014 | US20140199303 Stable Liquid Formulation of Etanercept |
| 07/17/2014 | US20140199300 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd1 maytansinoid immunoconjugate and rituzimab |
| 07/17/2014 | US20140199297 Triterpene glycoside and triterpene compositions and methods of using same |
| 07/17/2014 | US20140199288 Pharmaceutical compositions containing botulinum neurotoxin |
| 07/17/2014 | US20140199283 Formulations of albu-bche, preparation and uses thereof |
| 07/17/2014 | US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/17/2014 | US20140199249 Compositions for Depositing Agents Using Highly Volatile Silicone Solvents |
| 07/17/2014 | US20140199244 Controlled release system |
| 07/17/2014 | US20140199238 Targeting of Bone Marrow Neovasculature |
| 07/17/2014 | US20140199237 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 07/17/2014 | US20140199232 Targeted Therapeutic Nanoparticles |
| 07/16/2014 | EP2754718A1 Vascular endothelial myostatin mutant that mutates at atp binding sites |
| 07/16/2014 | EP2754682A1 Method for manufacturing block copolymer |
| 07/16/2014 | EP2754454A2 Non-steroidal anti-inflammatory drug derivatives |
| 07/16/2014 | EP2754453A1 Conjugate of a cationic antimicrobial peptide and of a fatty acid for use as an anti-cancer agent |
| 07/16/2014 | EP2754436A1 Biodegradable high-efficiency dengue vaccine, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2754435A1 Biodegradable carrier with adjustable zeta potentials and particle sizes, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2753362A1 Materials and methods for modulating immune responses |
| 07/16/2014 | EP2753361A1 Nanoparticle tumour vaccines |
| 07/16/2014 | EP2753360A1 Nanoparticle-peptide compositions |
| 07/16/2014 | EP2753350A1 Oral delivery for hemoglobin based oxygen carriers |
| 07/16/2014 | EP2753348A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate |
| 07/16/2014 | EP2753328A1 Dpp-iv inhibitor formulations |
| 07/16/2014 | EP2753309A1 Pharmaceutical composition for oral administration with a statin |
| 07/16/2014 | EP2753305A1 Coated suppositories |
| 07/16/2014 | EP2753303A1 Silicone coated implants |
| 07/16/2014 | EP2753302A1 Pharmaceutical invention of tapentadol |
| 07/16/2014 | CN203710540U 可降解放射性密封籽源连接链 Biodegradable radioactive sealed source is connected chain seed |
| 07/16/2014 | CN103930441A 附加糖链的多肽和含有该多肽的医药组合物 Polypeptides and pharmaceutical compositions containing the oligosaccharide chain polypeptide |
| 07/16/2014 | CN103930398A 具有改进的细胞内动力学的阳离子脂质 Has improved cationic lipids within the cell kinetics |
| 07/16/2014 | CN103930137A 卟啉-磷脂结合物微泡及其作为造影剂的用途 Porphyrin - phospholipid conjugate microbubbles and its use as a contrast agent |
| 07/16/2014 | CN103930135A 使用h-膦酸酯的纳米颗粒peg修饰 Use h- phosphonate modified nanoparticles peg |